Cargando…
Hypertension in autosomal-dominant polycystic kidney disease (ADPKD)
Cardiovascular (CV) complications are the major cause of death in autosomal-dominant polycystic kidney disease (ADPKD) patients. Hypertension is common in these patients even before the onset of renal insufficiency. Blood pressure (BP) elevation is a key factor in patient outcome, mainly owing to th...
Autores principales: | Sans-Atxer, Laia, Torra, Roser, Fernández-Llama, Patricia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4438388/ https://www.ncbi.nlm.nih.gov/pubmed/26064509 http://dx.doi.org/10.1093/ckj/sft031 |
Ejemplares similares
-
Tolvaptan in the treatment of autosomal dominant polycystic kidney disease: patient selection and special considerations
por: Sans-Atxer, Laia, et al.
Publicado: (2018) -
Renal volume and cardiovascular risk assessment in normotensive autosomal dominant polycystic kidney disease patients
por: Sans, Laia, et al.
Publicado: (2016) -
Cystatin C estimated glomerular filtration rate to assess renal function in early stages of autosomal dominant polycystic kidney disease
por: Sans, Laia, et al.
Publicado: (2017) -
Recent advances in the clinical management of autosomal dominant polycystic kidney disease
por: Torra, Roser
Publicado: (2019) -
Cellular abnormalities in Autosomal Dominant Polycystic Kidney Disease (ADPKD) fibroblasts
por: Moyes, S, et al.
Publicado: (2012)